Use of hydroxychloroquine to control immune response and hypercoagulability in patients with primary antiphospholipid syndrome

Saraiva-Mangolin, Sabrina; Vaz, Camila de Oliveira; Ruiz, Thays; Mazetto, Bruna Moraes; Orsi, Fernanda Andrade

Advanced search

Search - Use quotation marks to get a more specific result

Index

Field of knowledge

Start date

Betweenand

(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Use of hydroxychloroquine to control immune response and hypercoagulability in patients with primary antiphospholipid syndrome

Full text
Author(s):	Saraiva-Mangolin, Sabrina ^{[1, 2]} ; Vaz, Camila de Oliveira ^[2] ; Ruiz, Thays ^[1] ; Mazetto, Bruna Moraes ^[3] ; Orsi, Fernanda Andrade ^{[1, 4]} Total Authors: 5
Affiliation:	^[1] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP - Brazil ^[2] Univ Estadual Campinas, Sch Med Sci, Dept Clin Med, Campinas R Tessalia Vieira Camargo 126, BR-13083887 Campinas, SP - Brazil ^[3] Univ Estadual Campinas, Sch Med Sci, Campinas, SP - Brazil ^[4] Univ Estadual Campinas, Sch Med Sci, Dept Pathol, Campinas, SP - Brazil Total Affiliations: 4
Document type:	Letter
Source:	EUROPEAN JOURNAL OF INTERNAL MEDICINE; v. 90, p. 114-115, AUG 2021.
Web of Science Citations:	0
Abstract


FAPESP's process:	16/14172-6 - Investigation of the pathophysiological aspects and novel therapeutic approaches for thromboembolic disorders
Grantee:	Joyce Maria Annichino-Bizzacchi
Support Opportunities:	Research Projects - Thematic Grants

Short URL